Analysis Metabolite Name Measured Value Units Model Intervention
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.0000087peak areaAlzheimer’s disease model B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000010peak areaAlzheimer’s disease model Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000011peak areaAlzheimer’s disease model Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000013peak areaWild type Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000014peak areaWild type Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000015peak areaAlzheimer’s disease model B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000015peak areaAlzheimer’s disease model Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000015peak areaWild type Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000020peak areaWild type B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-10.000030peak areaWild type B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-1peak areaAlzheimer’s disease model B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-1peak areaAlzheimer’s disease model Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-1peak areaWild type B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-20.00025peak areaAlzheimer’s disease model Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-20.00026peak areaWild type B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-2peak areaAlzheimer’s disease model B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-2peak areaAlzheimer’s disease model Saline
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-2peak areaWild type B. breve MCC1274
Reversed phase UNSPECIFIED ION MODEβ-Cryptoxanthin-2peak areaWild type Saline

Return to search page
  logo